Cardiovascular diagnostics company Lantheus Holdings postpones IPO

By
A A A

Lantheus Holdings, which sells medical imaging agents used in the diagnosis of cardiovascular diseases, postponed its IPO on Wednesday, citing poor market conditions. The North Billerica, MA-based company was founded in 1956 and booked $286 million in sales for the 12 months ended 3/31/2014. Lantheus Holdings initially filed confidentially on 3/25/2014. Citi and Jefferies & Co. were set to be the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: News Headlines , IPOs

Referenced Stocks: LNTH

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Save Money in the Kitchen
Save Money in the Kitchen           

Stocks

Referenced

Most Active by Volume

32,241,314
  • $31.9299 ▼ 12.62%
21,867,171
  • $18.10 ▲ 1.23%
17,193,178
  • $26.189 ▲ 0.07%
13,064,425
  • $35.80 ▲ 1.27%
11,439,959
  • $20.367 ▲ 3.12%
10,881,001
  • $24.06 ▼ 28.20%
10,793,932
  • $15.04 ▲ 2.45%
9,865,850
  • $34.60 ▲ 0.79%
As of 7/29/2015, 10:31 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com